Taylor Wealth Management Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Taylor Wealth Management Partners's HALO Position: Q2 2022 in Review
Taylor Wealth Management Partners reduced its Halozyme (HALO) stake by 5.2% in Q2 2022, selling an estimated $187K and leaving 78,071 shares worth $3.44M. The position accounts for 1.95% of the portfolio, ranked #23.
Taylor Wealth Management Partners first reported a position in HALO in Q3 2016 and has held it in 24 quarters since. The position peaked at $4.32M in Q1 2018. 368 funds tracked by Wall St. Rank hold HALO as of Q2 2022.
- Taylor Wealth Management Partners held 78,071 shares of Halozyme worth $3.44M as of Q2 2022.
- Taylor Wealth Management Partners sold 4,313 Halozyme shares in Q2 2022, an estimated $187K.
- Halozyme made up 1.95% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #23 holding.
- Taylor Wealth Management Partners first reported a position in Halozyme in Q3 2016 and has held it in 24 quarters since.
- Taylor Wealth Management Partners's Halozyme position peaked at $4.32M in Q1 2018.
- 368 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.
Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.